RCOphth press statement -Ranibizumab for DMO Appeal
29/07/2011
The Royal College of Ophthalmologists has carefully reviewed the Final Appraisal Determination (FAD) relating to ‘Ranibizumab for the treatment of diabetic macular oedema’ published by NICE and has decided to make a formal appeal against the decision.
Short Notes from Professional Standards Committee July 2011
29/07/2011
The Short Notes from July's Professional Standards Committee are now available (Member's Login Required)
Patient Safety Update July 2011
29/07/2011
Patient Safety Update – a short and well informed update written by Mr Simon Kelly has been added to the College website.
Clinical Excellence Awards 2012 Information
28/07/2011
Update from ACCEA 29th July, 2011 Dear National Nominating Bodies, Please find below an announcement from the ACCEA Chair and Medical Director. This information will appear on the ACCEA website in the next few days. 2011 Round ACCEA usually aims to notify successful candidates and publish the list...
Paediatric Sub-committee Statement on Children’s Eye Health Campaign 2011
26/07/2011
Notice from the Paediatric Sub-committee regarding the Association of Optometrists (AOP) campaign on sight tests for children.
RCOphth Press Statement - Ranubizumab for DMO
20/07/2011
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE) Final Appraisal Determination Ranibizumab for the treatment of diabetic macular oedema (DMO) On 15th July NICE released their final appraisal of the use of ranibizumab (Lucentis) for the treatment of diabetic macular oedema. NICE...
Transfer of Care Guidance from the Royal Pharmaceutical Society
20/07/2011
The Royal Pharmaceutical Society, in collaboration with other royal colleges, patients, health and social care professionals has developed professional guidance that is closely mapped to a range of related national initiatives and guidance.
Ophthalmic Public Health: the invisible public health time bomb
20/07/2011
Sight loss is set to double by 2050, despite half of this being avoidable through early intervention and diagnosis. The College calls for public health outcome measures to include an eye health indicator.
GMC consultation on new child protection guidance
18/07/2011
'Protecting children and young people: the responsibilities of all doctors.' Important consultantation for all doctors not just those primarily involved in treating children.
Update on MHRA Medical Device Alert: Cryomatic probes manufactured by Keeler Ltd
18/07/2011
All probes are affected. The instructions for use contain inadequately validated re-processing methods. As a result there is a risk of cross infection. (MDA/2011/071 and update 18 July 2011 MDA/2011/081).
